You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

BICILLIN L-A Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Bicillin L-a patents expire, and when can generic versions of Bicillin L-a launch?

Bicillin L-a is a drug marketed by King Pharms Llc and Wyeth Ayerst and is included in two NDAs.

The generic ingredient in BICILLIN L-A is penicillin g benzathine. There are ninety-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the penicillin g benzathine profile page.

Drug patent expirations by year for BICILLIN L-A
Drug Prices for BICILLIN L-A

See drug prices for BICILLIN L-A

Recent Clinical Trials for BICILLIN L-A

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of TennesseePhase 2
National Institute of Allergy and Infectious Diseases (NIAID)Phase 3

See all BICILLIN L-A clinical trials

Pharmacology for BICILLIN L-A

US Patents and Regulatory Information for BICILLIN L-A

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms Llc BICILLIN L-A penicillin g benzathine INJECTABLE;INJECTION 050141-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
King Pharms Llc BICILLIN L-A penicillin g benzathine INJECTABLE;INJECTION 050141-001 Approved Prior to Jan 1, 1982 BC RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Wyeth Ayerst BICILLIN L-A penicillin g benzathine INJECTABLE;INJECTION 050131-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.